For Investors

Press Releases

ReWalk Robotics Demonstrates AI Autonomous Decision Making in Next Generation Exoskeleton Prototype

11/28/23

R&D Grant from the Israeli Technology Innovation Consortium Enabled the Successful Demonstration of a Working Prototype MARLBOROUGH, Mass. and BERLIN and YOKNEAM ILLIT, Israel , Nov. 28, 2023 (GLOBE NEWSWIRE) -- ReWalk Robotics , Ltd. (Nasdaq: RWLK) ("ReWalk" or the "Company"), a leading provider

ReWalk Robotics Reports Third Quarter 2023 Financial Results

11/14/23

Record Quarterly Revenue of $4.4 Million Successful Completion of AlterG Acquisition and Significant Progress of Integration Major Advancement in Efforts to Attain Medicare Payment Coverage of Exoskeletons MARLBOROUGH, Mass. , BERLIN and YOKNEAM ILLIT, Israel , Nov.

New Bill Facilitates Veteran Access to Powered Exoskeletons

11/10/23

Veterans STAND Act mandates regular evaluations of paralyzed Veterans and proactively identifies clinically-eligible Veterans for expedited procurement of personal exoskeletons MARLBOROUGH, Mass. and BERLIN and YOKNEAM ILIT, Israel , Nov. 10, 2023 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd.

ReWalk Robotics to Discuss Medicare’s Preliminary Payment Determination for ReWalk Personal Exoskeleton

11/07/23

Conference Call on Wednesday, November 8, 2023, at 8:30 a.m. EST MARLBOROUGH, Mass. , and BERLIN , and YOKNEAM ILLIT, Israel , Nov. 07, 2023 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”), a leading provider of innovative technologies that enable mobility and

ReWalk Robotics to Report Third Quarter 2023 Financial Results on November 14, 2023

11/07/23

MARLBOROUGH, Mass. and BERLIN and YOKNEAM ILIT, Israel , Nov. 07, 2023 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”) today announced that the Company will release its third quarter 2023 financial results on Tuesday, November 14, 2023 , prior to the U.S.

In Historic Move, Medicare Proposes Preliminary Reimbursement Level for ReWalk Personal Exoskeleton

11/06/23

Preliminary payment determination of $94,617 does not yet factor in currently available ReWalk system with Breakthrough Device Designation. CMS welcomes additional pricing materials at upcoming HCPCS meeting to reflect subsequent advancements in technology and pricing since ReWalk’s 2020

Medicare Coverage Solidified for ReWalk Personal Exoskeleton

11/02/23

2024 Medicare Home Health Rule finalizes Medicare benefit category for personal exoskeletons. Final rule expedites access for Medicare beneficiaries to exoskeleton technology that enables individuals with spinal cord injury to stand, walk, and navigate stairs and curbs in everyday life.

ReWalk Robotics Exhibits at the GITEX GLOBAL Intelligent Connectivity / AI Pavilion

10/18/23

A key theme for the event is that 2023 marks “The Year to imagine AI in Everything”. MARLBOROUGH, Mass. and BERLIN and YOKNEAM ILLIT, Israel , Oct. 18, 2023 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or “the Company”), a leading provider of innovative technologies that enable

ReWalk Robotics Offers Thanks to Former Director for His Loyal Service and Valuable Contributions

09/20/23

MARLBOROUGH, Mass. and BERLIN and YOKNEAM ILLIT, Israel , Sept. 20, 2023 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or “the Company”), a leading provider of innovative technologies that enable mobility and wellness in rehabilitation and daily life for individuals with

ReWalk Robotics Ltd. to Present Virtually at H.C. Wainwright 25th Annual Global Investment Conference

09/06/23

MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel , Sept. 06, 2023 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”) announced that Larry Jasinski , Chief Executive Officer, will present and host one-on-one meetings with investors virtually at the H.C.

ReWalk Robotics Announces Additional Change to Board of Directors

09/05/23

Number of Director Seats to be Reduced to Seven MARLBOROUGH, Mass. and BERLIN and YOKNEAM ILLIT, Israel , Sept. 05, 2023 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”), a leading provider of innovative technologies that enable mobility and wellness in

ReWalk Robotics Announces Closing of Acquisition of AlterG

08/11/23

Combined Company Expected to Expand Access for Patients to Innovative Rehabilitation Technologies for Use in Clinics and the Home Charles Remsberg Appointed Chief Sales Officer at ReWalk Robotics MARLBOROUGH, Mass. and BERLIN and YOKNEAM ILLIT, Israel , Aug.